Auvi-Q is set to return to the market February 14, 2017. Auvi-Q was withdrawn off the market in the past because improper dosing and later it was sold to Kaleo.
Many were wondering if Auvi-Q would ever return to the market again. Many patients liked the small packaging and the fact that it spoke instructions to you on how to use it properly.
Epinephrine auto injectors have been in the news a lot in the past year because of price increases.
After Auvi-Q left the market, the only manufacturer was Mylan who made Epipens. The cost of a two pack rose to over $600 from $100. After congressional hearings, Mylan came up with a $300 coupon and also made a generic version of Epipen for $300.
More recently, CVS Health announced that it will be selling a generic version of Epipen, Adrenaclick for $109.99. This is the same medicine as Epipen, but the way it is used is different. Patients will need to be retrained on the use of the Adrenaclick if they use that device.
All in all, this is good news for the consumer, as there will be a choice of 3 different epinephrine auto-injectors on the market soon. Epipen, Auvi-Q and Adrenaclick.
The makers of Auvi-Q have also come out with copay assistance programs for patients with high deductible plans. Kaleo said patients with commercial insurance will have a zero out of pocket cost. The cash price for Auvi-Q for those without insurance will be $360 for a dual pack. The price of the Auvi-Q when charged through insurance companies will be $4,500. They will also give patients the device with at least 12 months of expiration dating. Many patients have complained that for all the devices that when they get it, it expires in less than a year.
To learn about the efficacy of using the products after the expiration date, see below.
If you have any questions about which device is best for you, speak to your allergist or allergy doctor who can help you with coupons or discount programs to offset the costs of these devices.